Sponsor Dossier
Hospira
Sponsor Dossier for Hospira. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Aciclovir
- Brand: ANZATAX
- Brand: Atracurium
- Brand: Calcium
- Brand: Carboplatin
- Brand: Cisplatin
- Brand: DBL
- Brand: Desferoxamine
About
Hospira is an Australian Private Company with ABN 58 097 064 330, registered in Victoria. The entity status is Active. Hospira has traded under several business names, including David Bull Laboratories (from 2007), Mayne Pharma (from 2007), and Pfizer Melbourne (from 2017).
Portfolio
Hospira maintains a portfolio of 22 brands on the ARTG, of which 2 are indexable. Two brands have PBS-listed items. The portfolio includes oncology and infectious disease products such as ANZATAX, Atracurium, Carboplatin, Cisplatin, Docetaxel Injection, Doxorubicin, Emblaveo, and Gemcitabine IV Infusion.
Therapeutic focus
— Complementary Medicine: 20 brands — Oncology: 1 brand — Infectious Disease: 1 brand
PBS footprint
Two brands in the Hospira portfolio have PBS-listed items, with the latest schedule date being 2026-05-01.